Answer to Question 1
ANS: C
Haloperidol should be administered in a dosing interval of 2 to 4 weeks.
These dosing intervals are incorrect.
Answer to Question 2
ANS: A, C, E
Naratriptan therapy should be avoided in patients with coronary artery disease, as exemplified by a history of heart attack; a history of tobacco use, because of the vasoconstrictive secondary effects of nicotine; or a history of high blood pressure, which can be exacerbated by the vasoconstrictive effects of naratriptan.
A history of urinary frequency would not be significant to the administration of naratriptan.
Sleep patterns, related to amount of sleep, would not be significant to the administration of naratriptan.